A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.
Opinion | Moving Beyond the ‘Angelina Jolie Effect’ to Address Cancer Disparities
Giri is a medical oncologist who specializes in clinical cancer genetics. *Patient’s name has been changed In room A is Tonya*, a 41-year-old African-American woman